A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia.

@article{Zhang2001ADP,
  title={A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia.},
  author={Xiang Zhang and Dong Feng Zhou and Pei Zhang and Gui Ying Wu and Jiangling Su and Lian Yuan Cao},
  journal={The Journal of clinical psychiatry},
  year={2001},
  volume={62 11},
  pages={
          878-83
        }
}
  • Xiang Zhang, Dong Feng Zhou, +3 authors Lian Yuan Cao
  • Published in
    The Journal of clinical…
    2001
  • Psychology, Medicine
  • BACKGROUND Many studies have indicated that excess free radical formation may be involved in the pathogenesis of patients with schizophrenia. Some investigators suggested that the use of free radical scavengers might provide improvement in schizophrenia. The aim of this study was to determine the effectiveness and to evaluate the side effects of extract of Ginkgo biloba (EGb) plus haloperidol in chronic, treatment-resistant inpatients with schizophrenia. METHOD One hundred nine patients… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 39 CITATIONS

    Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia.

    VIEW 5 EXCERPTS
    CITES BACKGROUND & METHODS
    HIGHLY INFLUENCED

    A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia.

    VIEW 6 EXCERPTS
    CITES RESULTS & BACKGROUND
    HIGHLY INFLUENCED

    Evidence-based drug--herbal interactions.

    VIEW 3 EXCERPTS
    CITES METHODS & BACKGROUND
    HIGHLY INFLUENCED

    Natural Medicines for Psychotic Disorders